[EN] ARYLSULFONYLTHIOPHENECARBOXAMIDES AND ARYLSULFONYLFURANCARBOXAMIDES AS Kν3 POTASSIUM CHANNEL ACTIVATORS [FR] ARYLSULFONYLTHIOPHARMACOBOXAMIDES ET ARYLSULFONYLFURANCARBOXAMIDES EN TANT QU'ACTIVATEURS DE CANAUX POTASSIQUES Kν3
[EN] ARYLSULFONYLTHIOPHENECARBOXAMIDES AND ARYLSULFONYLFURANCARBOXAMIDES AS Kν3 POTASSIUM CHANNEL ACTIVATORS [FR] ARYLSULFONYLTHIOPHARMACOBOXAMIDES ET ARYLSULFONYLFURANCARBOXAMIDES EN TANT QU'ACTIVATEURS DE CANAUX POTASSIQUES Kν3
ARYLSULFONYLTHIOPHENECARBOXAMIDES AND ARYLSULFONYLFURANCARBOXAMIDES AS Kv3 POTASSIUM CHANNEL ACTIVATORS
申请人:H. Lundbeck A/S
公开号:US20220204489A1
公开(公告)日:2022-06-30
The present invention provides novel compounds which activate the Kv3 potassium channels. The compounds have the structure (I). Separate aspects of the invention are directed to pharmaceutical compositions comprising said compounds and use of the compounds to treat disorders responsive to the activation of Kv3 potassium channels.
[EN] ARYLSULFONYLTHIOPHENECARBOXAMIDES AND ARYLSULFONYLFURANCARBOXAMIDES AS Kν3 POTASSIUM CHANNEL ACTIVATORS<br/>[FR] ARYLSULFONYLTHIOPHARMACOBOXAMIDES ET ARYLSULFONYLFURANCARBOXAMIDES EN TANT QU'ACTIVATEURS DE CANAUX POTASSIQUES Kν3
申请人:H LUNDBECK AS
公开号:WO2020216919A1
公开(公告)日:2020-10-29
The present invention provides novel compounds which activate the Kv3 potassium channels. The compounds have the structure (I). Separate aspects of the invention are directed to pharmaceutical compositions comprising said compounds and use of the compounds to treat disorders responsive to the activation of Kv3 potassium channels.